Literature DB >> 10400730

Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2.

G N Milligan1.   

Abstract

Large numbers of polymorphonuclear leukocytes (PMNs) infiltrated the murine vaginal mucosa within 24 h after intravaginal inoculation with an attenuated strain of herpes simplex virus type 2 (HSV-2). The role of these cells in resolution of a primary genital infection and in protection of HSV-immune animals against challenge with a fully virulent HSV-2 strain was investigated. Depletion of greater than 95% of the PMNs at the vaginal mucosal surface prior to intravaginal inoculation with an attenuated HSV-2 strain resulted in significantly higher virus titers on days 3 to 7 but only slightly delayed resolution of the primary genital infection. These results suggest that neutrophils helped control the infection but that other immune mechanisms ultimately cleared the virus. Interestingly, depletion of PMNs from HSV-immune mice prior to challenge with a fully virulent HSV-2 strain resulted in a rise in virus titers to levels comparable to those of nonimmune mice and a more pronounced diminution of virus clearance from the vaginal mucosa despite the presence of HSV-specific B and T cells. Levels of gamma interferon (IFN-gamma) and HSV-specific antibody were comparable in neutrophil-depleted and control-treated immune mice following HSV-2 challenge, suggesting that RB6-8C5 treatment did not impair T- and B-cell function. Therefore, these results suggest that neutrophils play a role in limiting and clearing HSV-2 vaginal infections and that they are, in association with HSV-specific B and T cells, an important component in immune protection of the vaginal mucosa.

Entities:  

Mesh:

Year:  1999        PMID: 10400730      PMCID: PMC112717     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Prior herpes simplex virus type 2 infection as a risk factor for HIV infection.

Authors:  S D Holmberg; J A Stewart; A R Gerber; R H Byers; F K Lee; P M O'Malley; A J Nahmias
Journal:  JAMA       Date:  1988-02-19       Impact factor: 56.272

2.  Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor.

Authors:  B Perussia; M Kobayashi; M E Rossi; I Anegon; G Trinchieri
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

3.  HSV-2 replication sites, monocyte and lymphocytic cell infection and virion phagocytosis by neutrophils, in vesicular lesions on penile skin. Electronoptical studies of a biopsy.

Authors:  J Boddingius; H Dijkman; E Hendriksen; R Schift; E Stolz
Journal:  J Cutan Pathol       Date:  1987-06       Impact factor: 1.587

4.  Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs.

Authors:  L R Stanberry; S Kit; M G Myers
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

5.  Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha.

Authors:  M R Shalaby; M A Palladino; S E Hirabayashi; T E Eessalu; G D Lewis; H M Shepard; B B Aggarwal
Journal:  J Leukoc Biol       Date:  1987-03       Impact factor: 4.962

6.  Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival.

Authors:  A F Lopez; D J Williamson; J R Gamble; C G Begley; J M Harlan; S J Klebanoff; A Waltersdorph; G Wong; S C Clark; M A Vadas
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

7.  Direct inactivation of viruses by human granulocyte defensins.

Authors:  K A Daher; M E Selsted; R I Lehrer
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

8.  Genital reinfection after recovery from initial genital infection with herpes simplex virus type 2 in guinea pigs.

Authors:  L R Stanberry; D I Bernstein; S Kit; M G Myers
Journal:  J Infect Dis       Date:  1986-06       Impact factor: 5.226

9.  Phagocytosis of herpes simplex virus by human granulocytes and monocytes.

Authors:  J A Van Strijp; K P Van Kessel; M E van der Tol; A C Fluit; H Snippe; J Verhoef
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

10.  Defensins. Natural peptide antibiotics of human neutrophils.

Authors:  T Ganz; M E Selsted; D Szklarek; S S Harwig; K Daher; D F Bainton; R I Lehrer
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

View more
  40 in total

1.  Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity.

Authors:  A M Harandi; B Svennerholm; J Holmgren; K Eriksson
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  An innate antiviral pathway acting before interferons at epithelial surfaces.

Authors:  Marie B Iversen; Line S Reinert; Martin K Thomsen; Ieva Bagdonaite; Ramya Nandakumar; Natalia Cheshenko; Thaneas Prabakaran; Sergey Y Vakhrushev; Malgosha Krzyzowska; Sine K Kratholm; Fernando Ruiz-Perez; Steen V Petersen; Stanislas Goriely; Bo Martin Bibby; Kristina Eriksson; Jürgen Ruland; Allan R Thomsen; Betsy C Herold; Hans H Wandall; Sebastian Frische; Christian K Holm; Søren R Paludan
Journal:  Nat Immunol       Date:  2015-11-30       Impact factor: 25.606

3.  Differential polarization of immune responses by genetic cotransfer of chemokines changes the protective immunity of DNA vaccine against pseudorabies virus.

Authors:  Hyun A Yoon; Seong Kug Eo
Journal:  Immunology       Date:  2006-11-20       Impact factor: 7.397

4.  Comparison of the host immune response to herpes simplex virus 1 (HSV-1) and HSV-2 at two different mucosal sites.

Authors:  Min Zheng; Christopher D Conrady; Julie M Ward; Katie M Bryant-Hudson; Daniel J J Carr
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

5.  Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.

Authors:  L A Morrison; L Zhu; L G Thebeau
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  IL-36γ induces a transient HSV-2 resistant environment that protects against genital disease and pathogenesis.

Authors:  Jameson K Gardner; Melissa M Herbst-Kralovetz
Journal:  Cytokine       Date:  2018-08-15       Impact factor: 3.861

7.  The lack of RNA-dependent protein kinase enhances susceptibility of mice to genital herpes simplex virus type 2 infection.

Authors:  Daniel J J Carr; Todd Wuest; Lisa Tomanek; Robert H Silverman; Bryan R G Williams
Journal:  Immunology       Date:  2006-08       Impact factor: 7.397

8.  Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords.

Authors:  Alison J Johnson; Chin-Fun Chu; Gregg N Milligan
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms.

Authors:  Chin-Fun Chu; Michael G Meador; Christal G Young; Jane E Strasser; Nigel Bourne; Gregg N Milligan
Journal:  J Reprod Immunol       Date:  2007-10-24       Impact factor: 4.054

10.  Chemokines and Chemokine Receptors Critical to Host Resistance following Genital Herpes Simplex Virus Type 2 (HSV-2) Infection.

Authors:  M Thapa; D J J Carr
Journal:  Open Immunol J       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.